Investing in Apyx Medical Corporation (APYX)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)36.022384
Intrinsic value (DCF)20.401307
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

Established in 2011, Apyx Medical Corporation (ticker: APYX) is a leading medical technology company that focuses on developing, manufacturing, and marketing innovative solutions for the cosmetic and surgical markets. Their flagship product, the J-Plasma® system, is a patented plasma-based technology that has been used in various procedures such as skin resurfacing, soft tissue coagulation, and hemostasis. In addition to the J-Plasma® system, Apyx also offers the Renuvion® system, which combines the cutting-edge technology of J-Plasma® with traditional technologies for a more comprehensive approach to tissue rejuvenation and tightening. These products have gained significant market traction and are used by leading physicians in the United States and internationally. The company's commitment to innovation has led to the development of a robust pipeline of new products, including the Helium Plasma Technology platform, which has the potential to transform the aesthetic and gynecologic surgery markets. Apyx is dedicated to providing safe, effective, and long-lasting solutions for patients and healthcare professionals alike, positioning itself as a leader in the rapidly growing global medical aesthetics market. With a strong management team and a track record of success, Apyx is well-positioned for continued growth and success in the years to come.